Literature DB >> 18313715

Mutations generated in human immunodeficiency virus type 1 long terminal repeat during vertical transmission correlate with viral gene expression.

Roshni Mehta1, Vasudha Sundaravaradan, Nafees Ahmad.   

Abstract

We determined the effect of mutations generated in HIV-1 LTR on viral gene expression in six mother-infant pairs following vertical transmission. We show that the functional domains critical for LTR function, the promoter (TATAA), enhancers (three SpI and two NFkappaB sites), the modulatory region (two AP-I sites, two NFAT, one NF-IL6 site, one Ets-1, and one USF-1) and the TAR region were generally conserved among mother-infant pairs, although we observed several patient and pair specific mutations in these important domains. We then determined the promoter activity of our mother-infant LTR sequences by measuring CAT gene expression, which was driven by these LTRs and found that most of these HIV-1 LTRs derived from 6 mother-infant pairs were functional. However, mutations in the important transcription factor binding sites, including TATAA, SpI, NFkappaB, AP-I, NFAT, NF-IL6, Ets-1, USF-1 and TAR resulted in reduced LTR driven CAT gene expression. Taken together, conservation of functional domains in the LTR during vertical transmission supports the notion that a functional LTR is critical in viral replication and pathogenesis and mutations generated during the course of infection correlated with HIV-1 gene expression.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18313715      PMCID: PMC2430019          DOI: 10.1016/j.virol.2008.01.048

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  69 in total

1.  HIV-1 LTR subtype and perinatal transmission.

Authors:  J T Blackard; B Renjifo; W Fawzi; E Hertzmark; G Msamanga; D Mwakagile; D Hunter; D Spiegelman; N Sharghi; C Kagoma; M Essex
Journal:  Virology       Date:  2001-09-01       Impact factor: 3.616

2.  Functional roles for the TATA promoter and enhancers in basal and Tat-induced expression of the human immunodeficiency virus type 1 long terminal repeat.

Authors:  B Berkhout; K T Jeang
Journal:  J Virol       Date:  1992-01       Impact factor: 5.103

3.  Yeast and human TATA-binding proteins have nearly identical DNA sequence requirements for transcription in vitro.

Authors:  C R Wobbe; K Struhl
Journal:  Mol Cell Biol       Date:  1990-08       Impact factor: 4.272

4.  Maternal viral load, zidovudine treatment, and the risk of transmission of human immunodeficiency virus type 1 from mother to infant. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group.

Authors:  R S Sperling; D E Shapiro; R W Coombs; J A Todd; S A Herman; G D McSherry; M J O'Sullivan; R B Van Dyke; E Jimenez; C Rouzioux; P M Flynn; J L Sullivan
Journal:  N Engl J Med       Date:  1996-11-28       Impact factor: 91.245

5.  Interplay between NFBP and NF-kappaB modulates tat activation of the LTR.

Authors:  Thersa Sweet; Bassel E Sawaya; Kamel Khalili; Shohreh Amini
Journal:  J Cell Physiol       Date:  2005-08       Impact factor: 6.384

6.  Characterization of mother-infant HIV type 1 gag p17 sequences associated with perinatal transmission.

Authors:  T Hahn; E Matala; C Chappey; N Ahmad
Journal:  AIDS Res Hum Retroviruses       Date:  1999-07-01       Impact factor: 2.205

7.  Transcriptional trans activation by human immunodeficiency virus type 1 Tat requires specific coactivators that are not basal factors.

Authors:  C Suñé; M A García-Blanco
Journal:  J Virol       Date:  1995-05       Impact factor: 5.103

8.  The human immunodeficiency virus type 1 promoter contains a CATA box instead of a TATA box for optimal transcription and replication.

Authors:  Tim van Opijnen; Joost Kamoschinski; Rienk E Jeeninga; Ben Berkhout
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

9.  Evolution of the human immunodeficiency virus type 1 long terminal repeat promoter by conversion of an NF-kappaB enhancer element into a GABP binding site.

Authors:  K Verhoef; R W Sanders; V Fontaine; S Kitajima; B Berkhout
Journal:  J Virol       Date:  1999-02       Impact factor: 5.103

10.  Conservation of functional domains and limited heterogeneity of HIV-1 reverse transcriptase gene following vertical transmission.

Authors:  Vasudha Sundaravaradan; Tobias Hahn; Nafees Ahmad
Journal:  Retrovirology       Date:  2005-05-26       Impact factor: 4.602

View more
  2 in total

Review 1.  Features of Maternal HIV-1 Associated with Lack of Vertical Transmission.

Authors:  Nafees Ahmad; Aamir N Ahmad; Shahid N Ahmad
Journal:  Open Virol J       Date:  2017-03-23

2.  Genetic analysis of HIV-1 Circulating Recombinant Form 02_AG, B and C subtype-specific envelope sequences from Northern India and their predicted co-receptor usage.

Authors:  Ujjwal Neogi; Vikas Sood; Arpita Chowdhury; Shukla Das; Vishnampettai G Ramachandran; Vijesh K Sreedhar; Ajay Wanchu; Nilanjana Ghosh; Akhil C Banerjea
Journal:  AIDS Res Ther       Date:  2009-12-03       Impact factor: 2.250

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.